Early Diagnosis of Kidney Damage Associated With Tobacco Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03850756

Recruitment Status : Completed

First Posted : February 22, 2019

Last Update Posted : July 29, 2022

Sponsor:

Collaborators:

Instituto de Investigación Biomédica de Salamanca

Grupo de Investigación de Atención Primaria de Castilla y León

Salamanca University Hospital

Instituto de Salud Carlos III

Information provided by (Responsible Party):

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	April 1, 2022
Actual Study Completion Date :	July 1, 2022

Publications:

Prieto M, Vicente-Vicente L, Casanova AG, Hernández-Sánchez MT, Gomez-Marcos MA, Garcia-Ortiz L, Morales AI; members of the Biomarkers of kidney damage and tobacco. Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: an observational, prospective study protocol. BMJ Open. 2020 Mar 8;10(3):e032918. doi: 10.1136/bmjopen-2019-032918.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Tascón J, Prieto M, Casanova AG, Sanz FJ, Hernández Mezquita MA, Barrueco Ferrero M, Gomez-Marcos MA, Garcia-Ortiz L, Vicente-Vicente L, Morales AI, On Behalf Of Biotab Team. Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application. J Pers Med. 2022 Jun 24;12(7). pii: 1032. doi: 10.3390/jpm12071032.

To Top